Daratumumab, Bortezomib, Lenalidomide and Dexamethasone, Upfront Autologous Transplant and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma. // Transplantation and Cellular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S266663672600881X?dgcid=rss_sd_all
Daratumumab, Bortezomib, Lenalidomide and Dexamethasone, Upfront Autologous Transplant and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma. Transplantation and Cellular Therapy. https://www.sciencedirect.com/science/article/pii/S266663672600881X?dgcid=rss_sd_all
“Daratumumab, Bortezomib, Lenalidomide and Dexamethasone, Upfront Autologous Transplant and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma.” Transplantation and Cellular Therapy.
@article{article70368,
title = {Daratumumab, Bortezomib, Lenalidomide and Dexamethasone, Upfront Autologous Transplant and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma},
journal = {Transplantation and Cellular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S266663672600881X?dgcid=rss_sd_all}
}